AdaptHealthvsJohnson & Johnson

AHCO and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

AHCO

AdaptHealth Corp.

$7.25

Value $985M

-1.63%
AHCO's page

AdaptHealth (AHCO) has a market value of $985M and Johnson & Johnson (JNJ) $644B. Over the last year, with dividends, AHCO moved -20.3% and JNJ +36.6%. Dividend yield: AHCO none, JNJ 1.98%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AHCO$985M

    JNJ$644B

    JNJ is 653 times AHCO

  • Revenue, 12 months

    AHCO$3.4B

    JNJ$99.3B

    JNJ is 29 times AHCO

  • Net income, 12 months

    AHCO-$407M

    JNJ$16.1B

  • Operating margin

    AHCO-9.6%

    JNJ–

  • ROIC

    AHCO-8.0%

    JNJ12.4%

    20.4 points apart

  • P/E

    AHCO–

    JNJ40.0

  • Dividend yield

    AHCO0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    AHCO-69.0%

    JNJ+89.1%

    158.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AHCO-69.0%

JNJ+89.1%

5010015020020222023202420252026
Returns by period
PeriodAHCOWith dividendsJNJWith dividends
1 year since November 18, 2025-20.3%Price -20.3%+36.6%Price +33.6%
3 years since November 17, 2023-15.0%-5.3% a yearPrice -15.0%+94.2%+24.8% a yearPrice +78.3%
5 years since November 18, 2021-69.0%-20.9% a yearPrice -69.0%+89.1%+13.6% a yearPrice +64.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AHCOAdaptHealthJNJJohnson & Johnson

Valuation

AHCOJNJ
Valuation
Price$7.25$267.14
Market value$985M$644B
Enterprise value (EV)$2.9B$671B
P/E–40.0
P/E, 5-year median36.521.9
P/B0.87.9
EV/EBIT–37.8
Free cash flow yield8.3%3.2%

Results and growth

AHCOJNJ
Results and growth
Revenue, 12 months$3.4B$99.3B
Net income, 12 months-$407M$16.1B
Free cash flow, 12 months$82M$20.6B
Earnings per share, 12 months-$2.98$6.59
Revenue growth, year on year-0.5%6.1%
Revenue growth a year, past+25.2%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

AHCOJNJ
Margins and returns on capital
Gross margin15.8%67.6%
Operating margin-9.6%–
Net margin-11.8%16.2%
ROIC-8.0%12.4%
ROE-28.1%19.7%

Balance sheet

AHCOJNJ
Balance sheet
Cash–$17.2B
Total debt$2.0B$44.7B
Net debt / EBITDA36.81.1
Interest cover-3.2×18.0×

Dividends and buybacks

AHCOJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AHCO or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, AdaptHealth or Johnson & Johnson?

By market value, Johnson & Johnson ($644B) is about 653.3 times AdaptHealth ($985M), at today's prices.

How did AHCO and JNJ stock do over the last 5 years?

Since November 18, 2021, AHCO's price moved -69.0% and JNJ's +64.5%. With dividends: AHCO -69.0% (-20.9% a year), JNJ +89.1% (+13.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AHCO or JNJ?

The dividend yield at today's price is none for AdaptHealth and 1.98% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, AdaptHealth or Johnson & Johnson?

Over the last twelve months, the net margin was -11.8% for AdaptHealth and 16.2% for Johnson & Johnson, and the operating margin -9.6% and –. Revenue was $3.4B and $99.3B.

Which is the better investment, AdaptHealth or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.